This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Synthon B.v., Synthon IP Inc.. Active years: 2004-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Brno, CZ (2004)
- Krtiny, CZ (2009)
- Kritny, CZ (2011)
Company Filing History:
Years Active: 2004-2011
Title: Karel Pospisilik: Innovator in Pharmaceutical Chemistry
Introduction
Karel Pospisilik is a notable inventor based in Brno, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.
Latest Patents
Karel Pospisilik holds 4 patents to his name. His latest patents include a process for making duloxetine, where a compound of formula 10 is useful in the synthesis of this important medication. Additionally, he has developed a process for making desvenlafaxine, which is formed from venlafaxine using a demethylating agent that includes a metal sulfide, such as sodium sulfide, and optionally selenium.
Career Highlights
Throughout his career, Karel has worked with prominent companies in the pharmaceutical industry, including Synthon B.V. and Synthon IP Inc. His work has been instrumental in advancing the synthesis of key pharmaceutical compounds.
Collaborations
Karel has collaborated with esteemed colleagues such as Hans Jan Hoorn and Theodorus Hendricus Antonius Peters, contributing to various projects in the field of pharmaceutical innovation.
Conclusion
Karel Pospisilik's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to impact the development of important medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile